R. I. Christopherson

983 total citations
28 papers, 808 citations indexed

About

R. I. Christopherson is a scholar working on Molecular Biology, Infectious Diseases and Materials Chemistry. According to data from OpenAlex, R. I. Christopherson has authored 28 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Infectious Diseases and 5 papers in Materials Chemistry. Recurrent topics in R. I. Christopherson's work include Biochemical and Molecular Research (13 papers), HIV/AIDS drug development and treatment (8 papers) and Enzyme Structure and Function (5 papers). R. I. Christopherson is often cited by papers focused on Biochemical and Molecular Research (13 papers), HIV/AIDS drug development and treatment (8 papers) and Enzyme Structure and Function (5 papers). R. I. Christopherson collaborates with scholars based in Australia, United States and Sweden. R. I. Christopherson's co-authors include Mary Jones, Stephen P. Mulligan, Larissa Belov, Cristobal G. dos Remedios, Anthony J. Kemp, G.B. Ralston, Peter J. Lewis, R.G. Wake, Leonidas Phillips and Anthony E. T. Yeo and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Analytical Biochemistry.

In The Last Decade

R. I. Christopherson

28 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. I. Christopherson Australia 14 604 94 88 87 86 28 808
George A. Heavner United States 18 601 1.0× 141 1.5× 53 0.6× 38 0.4× 70 0.8× 48 1.4k
Mark Matteucci United States 17 909 1.5× 37 0.4× 59 0.7× 41 0.5× 68 0.8× 29 1.2k
Iker Valle Aramburu Germany 13 697 1.2× 74 0.8× 40 0.5× 76 0.9× 124 1.4× 16 1.1k
James P. Koch United States 13 659 1.1× 62 0.7× 46 0.5× 94 1.1× 16 0.2× 19 1.1k
Frederick E. Durr United States 16 484 0.8× 152 1.6× 61 0.7× 32 0.4× 89 1.0× 41 1.2k
William D. Wright United States 22 1.6k 2.6× 109 1.2× 90 1.0× 58 0.7× 28 0.3× 46 1.8k
Kevin D. Smith United Kingdom 21 838 1.4× 90 1.0× 57 0.6× 80 0.9× 15 0.2× 48 1.2k
Makoto Nakakido Japan 19 876 1.5× 262 2.8× 76 0.9× 57 0.7× 62 0.7× 81 1.2k
Xianbin Yang United States 22 926 1.5× 72 0.8× 142 1.6× 24 0.3× 47 0.5× 56 1.2k
Henriëtte W. M. Morselt Netherlands 21 693 1.1× 145 1.5× 116 1.3× 29 0.3× 29 0.3× 33 1.2k

Countries citing papers authored by R. I. Christopherson

Since Specialization
Citations

This map shows the geographic impact of R. I. Christopherson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. I. Christopherson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. I. Christopherson more than expected).

Fields of papers citing papers by R. I. Christopherson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. I. Christopherson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. I. Christopherson. The network helps show where R. I. Christopherson may publish in the future.

Co-authorship network of co-authors of R. I. Christopherson

This figure shows the co-authorship network connecting the top 25 collaborators of R. I. Christopherson. A scholar is included among the top collaborators of R. I. Christopherson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. I. Christopherson. R. I. Christopherson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaufman, Kimberley L., Lam P Ly, Matthew J. McKay, et al.. (2014). P17.47 * COMPREHENSIVE PROTEOMIC PROFILING OF BEVACIZUMAB-RESISTANT GLIOBLASTOMA MULTIFORME. Neuro-Oncology. 16(suppl 2). ii98–ii98. 25 indexed citations
2.
Yang, Fan, Kwang Hong Tay, Lijie Dong, et al.. (2010). Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIPL from degradation by the E3 ligase itch in human melanoma cells. Cell Death and Differentiation. 17(8). 1354–1367. 49 indexed citations
3.
Kaufman, Kimberley L., et al.. (2010). B-RAF: A contributor to the melanoma phenotype. The International Journal of Biochemistry & Cell Biology. 43(1). 29–32. 6 indexed citations
4.
Ellmark, Peter, Carl‐Magnus Högerkorp, Sara Ek, et al.. (2008). Phenotypic protein profiling of different B cell sub-populations using antibody CD-microarrays. Cancer Letters. 265(1). 98–106. 7 indexed citations
5.
Crossett, Ben, et al.. (2008). Fludarabine Induces Differential Expression of Proteins in Human Leukemia and Lymphoma Cells. Nucleosides Nucleotides & Nucleic Acids. 27(6-7). 634–640. 2 indexed citations
6.
Christopherson, R. I., et al.. (2004). Cloning and Expression of Malarial Pyrimidine Enzymes. Nucleosides Nucleotides & Nucleic Acids. 23(8-9). 1459–1465. 7 indexed citations
7.
Menz, R. Ian, Olivier Cinquin, & R. I. Christopherson. (2002). The identification, cloning and functional expression of the gene encoding orotidine 5'-monophosphate (OMP) decarboxylase fromPlasmodium falciparum. Annals of Tropical Medicine and Parasitology. 96(5). 469–476. 3 indexed citations
8.
Christopherson, R. I., et al.. (1998). Reversal of vinblastine transport by chlorpromazine in membrane vesicles from multidrug-resistant human CCRF-CEM leukaemia cells. British Journal of Cancer. 78(3). 321–327. 11 indexed citations
9.
Yeo, Anthony E. T., et al.. (1997). Effects of folic and folinic acids on the activities of cycloguanil and WR99210 againstPlasmodium falciparumin erythrocytic culture. Annals of Tropical Medicine and Parasitology. 91(1). 17–23. 15 indexed citations
10.
Dunn, Ian S., et al.. (1996). Purine deoxynucleoside metabolism in human melanoma cells with a high spontaneous mutation rate. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 350(1). 229–238. 5 indexed citations
11.
Christopherson, R. I., et al.. (1994). Radioassay of Bifunctional 5-Aminoimidazole-4-carboxamide Ribotide Transformylase-IMP Cyclohydrolase by Thin-Layer Chromatography. Analytical Biochemistry. 221(2). 401–404. 7 indexed citations
12.
Lewis, Peter J., G.B. Ralston, R. I. Christopherson, & R.G. Wake. (1990). Identification of the replication terminator protein binding sites in the terminus region of theBacillus subtilis chromosome and stoichiometry of the binding. Journal of Molecular Biology. 214(1). 73–84. 49 indexed citations
13.
Christopherson, R. I., et al.. (1990). Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemia.. Journal of Biological Chemistry. 265(19). 11377–11381. 60 indexed citations
14.
Brooke, John, et al.. (1990). Cytotoxic effects of dihydroorotase inhibitors upon human CCRF-CEM leukemia.. PubMed. 50(24). 7793–8. 12 indexed citations
15.
Kemp, Anthony J., et al.. (1989). Dual effects of pyrazofurin and 3-deazauridine upon pyrimidine and purine biosynthesis in mouse L1210 leukemia.. PubMed. 49(10). 2645–50. 14 indexed citations
16.
Kemp, Anthony J., et al.. (1986). Effects of acivicin and dichloroallyl lawsone upon pyrimidine biosynthesis in mouse L1210 leukemia cells.. Journal of Biological Chemistry. 261(32). 14891–14895. 34 indexed citations
17.
Christopherson, R. I., et al.. (1981). Inhibition of synthesis of lung proteins by halothane.. PubMed. 19(3). 520–4. 12 indexed citations
18.
Christopherson, R. I. & Mary Jones. (1980). The effects of pH and inhibitors upon the catalytic activity of the dihydroorotase of multienzymatic protein pyr1-3 from mouse Ehrlich ascites carcinoma.. Journal of Biological Chemistry. 255(8). 3358–3370. 39 indexed citations
19.
Christopherson, R. I. & Mary Jones. (1980). The overall synthesis of L-5,6-dihydroorotate by multienzymatic protein pyr1-3 from hamster cells. Kinetic studies, substrate channeling, and the effects of inhibitors.. Journal of Biological Chemistry. 255(23). 11381–11395. 71 indexed citations
20.
Christopherson, R. I. & Mary Jones. (1979). Interconversion of carbamayl-L-aspartate and L-dihydroorotate by dihydroorotase from mouse Ehrlich ascites carcinoma.. Journal of Biological Chemistry. 254(24). 12506–12512. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George A. Heavner Breakdown of academic impact, for papers by Mark Matteucci Breakdown of academic impact, for papers by Iker Valle Aramburu Breakdown of academic impact, for papers by James P. Koch Breakdown of academic impact, for papers by Frederick E. Durr Breakdown of academic impact, for papers by William D. Wright Breakdown of academic impact, for papers by Kevin D. Smith Breakdown of academic impact, for papers by Makoto Nakakido Breakdown of academic impact, for papers by Xianbin Yang Breakdown of academic impact, for papers by Henriëtte W. M. Morselt
Rankless by CCL
2026